| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $25.97M | - | |
| COO | 145.4K | $8.78M | - | |
| CFO | 95.3K | $5.76M | - | |
| Other | 68.1K | $4.11M | - | |
| Other | 52.6K | $3.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 | Jane Wright-Mitchell65 | General Counsel | Sale+OE | 10,000 | $26.00 | $260,000.00 | -76.2% | -7.5% | -1.1% | |
| Jul 26, 2021 | Jeff Fairman | VP, Research | Sale+OE | 4,750 | $22.70 | $107,825.00 | -48.0% | +0.2% | +5.0% | |
| Jul 20, 2021 | Grant Pickering50 | Chief Executive Officer | Sale+OE | 15,000 | $22.85 | $342,685.50 | -2.5% | +0.1% | +6.5% | |
| Jun 28, 2021 | Jeff Fairman | VP, Research | Sale+OE | 4,750 | $24.37 | $115,769.84 | -48.0% | +9.1% | -13.2% | |
| Jun 24, 2021 | Grant Pickering50 | Chief Executive Officer | Sale+OE | 13,863 | $23.09 | $320,123.31 | -2.3% | +11.1% | -16.7% | |
| Jun 22, 2021 | Grant Pickering50 | Chief Executive Officer | Sale+OE | 1,137 | $22.05 | $25,067.15 | -0.2% | +19.9% | -3.7% | |
| Jun 7, 2021 | Jeff Fairman | VP, Research | Sale+OE | 9,500 | $22.50 | $213,750.00 | -64.9% | +12.7% | -13.9% | |
| Jun 4, 2021 | Grant Pickering50 | Chief Executive Officer | Sale+OE | 15,098 | $22.13 | $334,059.57 | -2.5% | +21.6% | +0.0% | |
| May 28, 2021 | Grant Pickering50 | Chief Executive Officer | Sale+OE | 14,902 | $22.11 | $329,493.56 | -2.5% | +18.7% | +23.8% | |
| Mar 26, 2021 | Jeff Fairman | VP, Research | Sale+OE | 4,750 | $23.88 | $113,433.24 | -77.1% | -1.5% | +0.8% |